Matthew Boland Yurgelun, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 35 | 2025 | 388 | 12.770 |
Why?
|
Germ-Line Mutation | 29 | 2024 | 1885 | 3.700 |
Why?
|
Colorectal Neoplasms | 32 | 2024 | 6974 | 3.050 |
Why?
|
Genetic Testing | 31 | 2025 | 3591 | 2.550 |
Why?
|
DNA Mismatch Repair | 14 | 2023 | 431 | 2.260 |
Why?
|
Pancreatic Neoplasms | 21 | 2024 | 5446 | 1.970 |
Why?
|
Microsatellite Instability | 11 | 2023 | 726 | 1.490 |
Why?
|
DNA Glycosylases | 6 | 2020 | 125 | 1.480 |
Why?
|
Genetic Predisposition to Disease | 37 | 2024 | 18065 | 1.480 |
Why?
|
Neoplastic Syndromes, Hereditary | 9 | 2024 | 249 | 1.440 |
Why?
|
Genetic Counseling | 10 | 2024 | 635 | 1.330 |
Why?
|
Intestinal Polyposis | 3 | 2020 | 42 | 1.290 |
Why?
|
Adenomatous Polyposis Coli | 4 | 2021 | 219 | 1.120 |
Why?
|
Adenoma | 6 | 2023 | 2159 | 1.010 |
Why?
|
Adenocarcinoma | 11 | 2024 | 6395 | 0.970 |
Why?
|
Endometrial Neoplasms | 5 | 2024 | 1382 | 0.930 |
Why?
|
Carcinoma, Pancreatic Ductal | 9 | 2024 | 1757 | 0.810 |
Why?
|
Jews | 2 | 2020 | 359 | 0.760 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.740 |
Why?
|
Germ Cells | 8 | 2022 | 644 | 0.720 |
Why?
|
Stomach Neoplasms | 6 | 2024 | 1481 | 0.700 |
Why?
|
MutS Homolog 2 Protein | 5 | 2023 | 200 | 0.680 |
Why?
|
Genes, APC | 1 | 2020 | 145 | 0.680 |
Why?
|
BRCA2 Protein | 3 | 2022 | 802 | 0.630 |
Why?
|
Stomach Diseases | 1 | 2020 | 134 | 0.620 |
Why?
|
Watchful Waiting | 2 | 2020 | 492 | 0.610 |
Why?
|
Colectomy | 3 | 2020 | 696 | 0.590 |
Why?
|
DNA Mutational Analysis | 6 | 2018 | 4120 | 0.580 |
Why?
|
Colonic Neoplasms | 2 | 2021 | 2541 | 0.570 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1155 | 0.560 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 314 | 0.510 |
Why?
|
Heredity | 5 | 2021 | 149 | 0.490 |
Why?
|
High-Throughput Nucleotide Sequencing | 10 | 2021 | 3671 | 0.480 |
Why?
|
Neoplasms | 11 | 2024 | 22371 | 0.480 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2015 | 117 | 0.450 |
Why?
|
Risk Assessment | 16 | 2025 | 24315 | 0.440 |
Why?
|
Humans | 97 | 2025 | 768166 | 0.430 |
Why?
|
Ovarian Neoplasms | 4 | 2023 | 4916 | 0.420 |
Why?
|
Medical History Taking | 5 | 2020 | 779 | 0.420 |
Why?
|
Base Pair Mismatch | 1 | 2012 | 93 | 0.390 |
Why?
|
Radiotherapy | 2 | 2020 | 1502 | 0.380 |
Why?
|
Pedigree | 6 | 2021 | 4539 | 0.360 |
Why?
|
Genetics, Population | 1 | 2015 | 944 | 0.350 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 11 | 2025 | 11878 | 0.350 |
Why?
|
ras Proteins | 2 | 2015 | 1058 | 0.350 |
Why?
|
Polyps | 1 | 2012 | 200 | 0.340 |
Why?
|
Penetrance | 4 | 2022 | 385 | 0.330 |
Why?
|
Gene Frequency | 4 | 2020 | 3623 | 0.330 |
Why?
|
Early Detection of Cancer | 7 | 2024 | 3239 | 0.320 |
Why?
|
Colonoscopy | 3 | 2020 | 1409 | 0.320 |
Why?
|
Phenotype | 9 | 2021 | 16726 | 0.300 |
Why?
|
DNA Repair | 3 | 2018 | 2050 | 0.300 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2954 | 0.300 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3603 | 0.290 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2024 | 957 | 0.280 |
Why?
|
Female | 49 | 2025 | 397192 | 0.280 |
Why?
|
Microsatellite Repeats | 3 | 2021 | 785 | 0.270 |
Why?
|
Neuroendocrine Tumors | 2 | 2025 | 659 | 0.270 |
Why?
|
Adenomatous Polyposis Coli Protein | 3 | 2018 | 182 | 0.270 |
Why?
|
Electronic Health Records | 1 | 2024 | 4887 | 0.270 |
Why?
|
Mutation | 10 | 2023 | 30238 | 0.260 |
Why?
|
Male | 42 | 2025 | 364719 | 0.250 |
Why?
|
Middle Aged | 37 | 2025 | 223492 | 0.240 |
Why?
|
Risk Factors | 17 | 2023 | 74944 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4528 | 0.240 |
Why?
|
Adult | 30 | 2025 | 223646 | 0.210 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5863 | 0.210 |
Why?
|
Registries | 2 | 2020 | 8375 | 0.210 |
Why?
|
Precancerous Conditions | 3 | 2024 | 985 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 90 | 0.200 |
Why?
|
Americas | 1 | 2022 | 110 | 0.200 |
Why?
|
Esophageal Neoplasms | 2 | 2024 | 1668 | 0.190 |
Why?
|
Aged | 28 | 2025 | 171504 | 0.190 |
Why?
|
Age Factors | 5 | 2021 | 18412 | 0.190 |
Why?
|
Esophagogastric Junction | 2 | 2024 | 351 | 0.180 |
Why?
|
Risk | 4 | 2021 | 9613 | 0.180 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 97 | 0.170 |
Why?
|
Neutropenia | 2 | 2023 | 892 | 0.170 |
Why?
|
Anus Neoplasms | 1 | 2024 | 336 | 0.170 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15454 | 0.170 |
Why?
|
Smad4 Protein | 1 | 2020 | 193 | 0.160 |
Why?
|
Heterozygote | 3 | 2022 | 2798 | 0.160 |
Why?
|
Cohort Studies | 7 | 2025 | 41754 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 314 | 0.160 |
Why?
|
Young Adult | 11 | 2024 | 60066 | 0.160 |
Why?
|
Models, Genetic | 3 | 2021 | 3447 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1027 | 0.150 |
Why?
|
Genes, BRCA2 | 2 | 2021 | 593 | 0.150 |
Why?
|
Chemoprevention | 2 | 2018 | 327 | 0.140 |
Why?
|
Genes, BRCA1 | 2 | 2021 | 755 | 0.140 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26379 | 0.140 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21206 | 0.140 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12795 | 0.140 |
Why?
|
Gastric Mucosa | 1 | 2020 | 602 | 0.140 |
Why?
|
Genes, p16 | 1 | 2017 | 159 | 0.130 |
Why?
|
Sex Factors | 2 | 2021 | 10632 | 0.130 |
Why?
|
Inheritance Patterns | 1 | 2018 | 344 | 0.130 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13676 | 0.120 |
Why?
|
Intestine, Small | 1 | 2021 | 1217 | 0.120 |
Why?
|
New Zealand | 1 | 2015 | 360 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2023 | 1767 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 557 | 0.110 |
Why?
|
Cultural Characteristics | 1 | 2015 | 250 | 0.110 |
Why?
|
Anilides | 1 | 2017 | 413 | 0.110 |
Why?
|
Body Composition | 1 | 2023 | 2462 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2603 | 0.110 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 606 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3556 | 0.110 |
Why?
|
Genetic Variation | 2 | 2019 | 6611 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11095 | 0.100 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6847 | 0.100 |
Why?
|
Endoscopy | 1 | 2022 | 1854 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 190 | 0.100 |
Why?
|
Syndrome | 1 | 2019 | 3272 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2744 | 0.100 |
Why?
|
Biliary Tract Neoplasms | 1 | 2014 | 187 | 0.100 |
Why?
|
Paclitaxel | 3 | 2024 | 1733 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1640 | 0.100 |
Why?
|
Organoplatinum Compounds | 3 | 2019 | 408 | 0.100 |
Why?
|
Prognosis | 4 | 2022 | 30010 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2020 | 12465 | 0.090 |
Why?
|
Australia | 1 | 2015 | 1265 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 561 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 614 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2025 | 59629 | 0.090 |
Why?
|
Oncogenes | 1 | 2016 | 1234 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9538 | 0.090 |
Why?
|
Vitamins | 1 | 2019 | 1638 | 0.090 |
Why?
|
Fluorouracil | 3 | 2022 | 1652 | 0.090 |
Why?
|
Canada | 1 | 2015 | 2130 | 0.080 |
Why?
|
Prevalence | 3 | 2024 | 15869 | 0.080 |
Why?
|
Telemedicine | 2 | 2024 | 3109 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3044 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3135 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4058 | 0.070 |
Why?
|
Odds Ratio | 1 | 2020 | 9669 | 0.070 |
Why?
|
Carcinoma | 1 | 2019 | 2332 | 0.070 |
Why?
|
Age of Onset | 1 | 2015 | 3347 | 0.070 |
Why?
|
Models, Statistical | 1 | 2022 | 5107 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3533 | 0.070 |
Why?
|
Counseling | 1 | 2015 | 1554 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4260 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2536 | 0.070 |
Why?
|
Hysterectomy | 1 | 2012 | 863 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9118 | 0.070 |
Why?
|
Leucovorin | 2 | 2019 | 643 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2810 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2830 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5926 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39348 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3445 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2333 | 0.060 |
Why?
|
Deoxycytidine | 2 | 2024 | 887 | 0.060 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 371 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5703 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2894 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 547 | 0.060 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5706 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20227 | 0.060 |
Why?
|
Adolescent | 5 | 2021 | 89169 | 0.060 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2005 | 119 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5458 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2059 | 0.050 |
Why?
|
Chemokines, CXC | 1 | 2005 | 420 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9615 | 0.050 |
Why?
|
Somatostatin | 1 | 2025 | 458 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4362 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6340 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4755 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5804 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10399 | 0.050 |
Why?
|
Medical Oncology | 2 | 2024 | 2346 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6283 | 0.050 |
Why?
|
Osteoclasts | 1 | 2005 | 713 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4912 | 0.040 |
Why?
|
Albumins | 1 | 2023 | 577 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2023 | 631 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 335 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2023 | 386 | 0.040 |
Why?
|
Chemokine CXCL12 | 2 | 2017 | 457 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 637 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3415 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 13045 | 0.040 |
Why?
|
Edema | 1 | 2023 | 765 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2914 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 65371 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 600 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 620 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5520 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 819 | 0.040 |
Why?
|
Hyperbilirubinemia | 1 | 2017 | 74 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 147 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.030 |
Why?
|
Epistaxis | 1 | 2017 | 117 | 0.030 |
Why?
|
Intestinal Fistula | 1 | 2017 | 146 | 0.030 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 186 | 0.030 |
Why?
|
Endosonography | 1 | 2019 | 626 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 560 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2017 | 254 | 0.030 |
Why?
|
Animals | 4 | 2023 | 169246 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54926 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2219 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2433 | 0.030 |
Why?
|
Intestines | 1 | 2023 | 1909 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12840 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6514 | 0.030 |
Why?
|
California | 1 | 2017 | 1438 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2017 | 564 | 0.030 |
Why?
|
Family | 1 | 2024 | 3209 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1447 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2005 | 2565 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8647 | 0.020 |
Why?
|
Stem Cells | 1 | 2005 | 3537 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 872 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36535 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3329 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1494 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 799 | 0.020 |
Why?
|
Physician's Role | 1 | 2017 | 925 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.020 |
Why?
|
Attitude to Health | 1 | 2019 | 2025 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
Internal Medicine | 1 | 2017 | 1064 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7214 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81762 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1041 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3628 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2211 | 0.020 |
Why?
|
Anxiety | 1 | 2024 | 4672 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4978 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2846 | 0.020 |
Why?
|
United States | 1 | 2015 | 73039 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10760 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3228 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4786 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4045 | 0.020 |
Why?
|
Mice | 2 | 2023 | 82029 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3514 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12421 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7852 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12077 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2540 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11669 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3114 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 22379 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12543 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11244 | 0.010 |
Why?
|
Depression | 1 | 2024 | 8230 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6526 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3681 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3833 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7454 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10474 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4428 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13290 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 660 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9495 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4580 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9263 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8616 | 0.010 |
Why?
|
Monocytes | 1 | 2005 | 2605 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3409 | 0.010 |
Why?
|
Child | 1 | 2020 | 80917 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36743 | 0.010 |
Why?
|